|
|||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Saturday, May 31
Phase 2 trial of a DNA vaccine
by
All About MS
on Sat 31 May 2008 05:00 PM CST
BHT-3009 is a tolerizing DNA vaccine for MS, encoding full-length human myelin basic protein. Relapsing-remitting MS patients were randomized 1:1:1 into three groups: placebo, 0.5mg BHT- more »
Friday, May 30
Study with Interferon Beta-1b and PMS
by
All About MS
on Fri 30 May 2008 12:00 AM CST
Study with Interferon Beta-1b and PMS
Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple more »
Monday, May 19
Drug Trial – Trimesta
by
All About MS
on Mon 19 May 2008 08:08 AM CST
We are developing Trimesta™ as an oral, immunomodulatory and anti-inflammatory agent for the North American market. Estriol has been approved and marketed throughout Europe and more »
Thursday, May 8
Study - DNA Vaccines May Offer Hope In MS
by
All About MS
on Thu 08 May 2008 02:00 AM CST
Authors from the VA North Texas Health Care System Neurology Section and the Department of Neurology at the University of Texas Southwestern Medical Center at Dallas have highlighted the potential benefits for DNA-based vaccine administration in more »
Tuesday, May 6
Atacicept Phase 2 Clinical Trial In Relapsing Multiple Sclerosis
by
All About MS
on Tue 06 May 2008 08:16 AM CST
ZymoGenetics, Inc. (NASDAQ:ZGEN), announced that its development partner Merck Serono, a division of Merck KGaA, Darmstadt, Germany, has initiated a Phase 2 clinical trial to more »
|
||
